X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE LUPIN LTD SUVEN LIFE/
LUPIN LTD
 
P/E (TTM) x 17.4 26.4 65.9% View Chart
P/BV x 3.6 2.8 130.1% View Chart
Dividend Yield % 0.6 0.6 105.7%  

Financials

 SUVEN LIFE   LUPIN LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
LUPIN LTD
Mar-18
SUVEN LIFE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs2511,465 17.1%   
Low Rs155727 21.3%   
Sales per share (Unadj.) Rs49.1349.6 14.1%  
Earnings per share (Unadj.) Rs9.75.6 174.8%  
Cash flow per share (Unadj.) Rs11.429.6 38.5%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Dividend yield (eoy) %0.70.5 162.1%  
Book value per share (Unadj.) Rs60.3300.3 20.1%  
Shares outstanding (eoy) m127.28452.08 28.2%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.13.1 131.7%   
Avg P/E ratio x20.9197.2 10.6%  
P/CF ratio (eoy) x17.837.1 48.1%  
Price / Book Value ratio x3.43.6 92.2%  
Dividend payout %15.490.0 17.2%   
Avg Mkt Cap Rs m25,825495,502 5.2%   
No. of employees `0001.117.0 6.3%   
Total wages/salary Rs m61328,647 2.1%   
Avg. sales/employee Rs Th5,832.69,273.6 62.9%   
Avg. wages/employee Rs Th571.51,681.0 34.0%   
Avg. net profit/employee Rs Th1,153.8147.4 782.6%   
INCOME DATA
Net Sales Rs m6,253158,042 4.0%  
Other income Rs m2331,504 15.5%   
Total revenues Rs m6,485159,545 4.1%   
Gross profit Rs m1,98231,475 6.3%  
Depreciation Rs m21310,859 2.0%   
Interest Rs m462,044 2.3%   
Profit before tax Rs m1,95520,076 9.7%   
Minority Interest Rs m0-71 0.0%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m7182,885 24.9%   
Profit after tax Rs m1,2372,513 49.2%  
Gross profit margin %31.719.9 159.1%  
Effective tax rate %36.714.4 255.7%   
Net profit margin %19.81.6 1,244.2%  
BALANCE SHEET DATA
Current assets Rs m5,622122,095 4.6%   
Current liabilities Rs m1,16850,956 2.3%   
Net working cap to sales %71.245.0 158.3%  
Current ratio x4.82.4 201.0%  
Inventory Days Days8185 96.3%  
Debtors Days Days36120 30.0%  
Net fixed assets Rs m3,325129,876 2.6%   
Share capital Rs m127904 14.1%   
"Free" reserves Rs m7,547134,866 5.6%   
Net worth Rs m7,674135,771 5.7%   
Long term debt Rs m1464,245 0.0%   
Total assets Rs m9,135263,054 3.5%  
Interest coverage x43.210.8 399.3%   
Debt to equity ratio x00.5 0.4%  
Sales to assets ratio x0.70.6 113.9%   
Return on assets %14.01.7 811.0%  
Return on equity %16.11.9 870.9%  
Return on capital %26.03.7 699.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06653,141 9.5%   
Fx outflow Rs m2,00119,335 10.4%   
Net fx Rs m3,06533,807 9.1%   
CASH FLOW
From Operations Rs m69917,512 4.0%  
From Investments Rs m-6-14,073 0.0%  
From Financial Activity Rs m-577-14,921 3.9%  
Net Cashflow Rs m116-11,482 -1.0%  

Share Holding

Indian Promoters % 63.4 46.6 136.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.1 361.4%  
Shareholders   37,287 98,259 37.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  DR. DATSONS LABS  ELDER PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 14, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS